Skip to content
Open access

Antibody Repertoire Modulation Alters Alzheimer’s Pathology and Behavior in the 5XFAD Mouse Model 2267871

Jul 2026 · Journal of Immunology · Vol 215 · 0 citations

TL;DR

The results suggest that specific antibodies restrict the progression of cognitive impairment in 5XFAD mice.

Abstract

Alzheimer’s Disease (AD) is one of the most prominent neurodegenerative diseases. The disease is associated with amyloid-β (Aβ) accumulation, protein tau neurofibrillary tangles, neuronal loss, and chronic inflammation in the brain. Aβ plaque accumulation leads to an inflammatory response orchestrated by resident microglia and ultimately neurodegeneration. Recent literature suggests that the immune system, particularly antibodies, plays a key role in disease progression. We sought to characterize the role of specific antibodies in AD by manipulating the repertoire of the 5XFAD model system. We crossed MD4 mice, which have a B cell repertoire restricted to an irrelevant antigen, with 5XFAD mice, which model early onset Alzheimer’s disease, to address whether specific antibodies modulate disease progression. These mice underwent a battery of behavioral tests to measure cognitive impairment, followed by tissue collection for analysis of plaque accumulation, microglia activation, and antibody deposition by immunohistochemistry (IHC). Analysis of 5XFAD brains using monoclonal antibodies specific for IgG subclasses revealed an increase in microglia-associated IgG1 within the hippocampus compared to non-transgenic littermates. MD4 5XFAD double transgenic mice had sex specific increases in cognitive impairment, including increased mobility in the open field, nighttime hyperactivity, and decreased spontaneous alternation in a cross-maze compared to 5XFAD littermates. By IHC, we detected a modest trending increase in amyloid-β plaque accumulation at 10 months of age in double transgenic mice compared to 5xFAD brain. The wildtype and MD4 mice brains did not display any amyloid-β plaque accumulation, as expected. Our results suggest that specific antibodies restrict the progression of cognitive impairment in 5XFAD mice. Ongoing work is aimed at uncovering the specificities and origin of the spontaneous antibodies that can be found within the brains of 5XFAD mice. The National Institute of Health (NIH) Neuroimmunology (NEUR)

Read PDF

Similar papers

Review Open access Sep 2026

Is there a role for B cells in Alzheimer's disease?

The phenotypic and functional alterations of B cells in AD are reviewed, integrating evidence from experimental models and human studies to evaluate whether B cells constitute an underappreciated component of the adaptive immune response in AD and whether they represent a compelling immunotherapeutic target.

Eva-Loren Charavner, S. Fillatreau, M. El Behi · 0 citations
Review Open access Aug 2026

Microglia-mediated neuroinflammation in Alzheimer’s disease: mechanisms and emerging therapeutic targets

A “cellular state–pathological network–therapeutic window” framework is proposed and the roles of microglia in amyloid-β plaque seeding and compaction, NLRP3 inflammasome activation, mitochondrial DNA–cGAS–STING signaling, complement-mediated synaptic engulfment, and bidirectional microglia–tau feedback are systematica...

Lian-Jing Xu, Ying Zhang, Li Jiang et al. · 0 citations
Review Open access Aug 2026

Disentangling the role of adaptive immunity in Alzheimer’s disease

Alzheimer’s disease (AD), the most common age-related neurodegenerative disorder, is characterized by progressive synaptic and neuronal loss, amyloid-β deposition, hyperphosphorylated tau accumulation, and chronic neuroinflammation, traditionally attributed primarily to the innate immune system. Increasing evidence,...

Marco Zattoni, Ludwig Aigner · 0 citations
Review Sep 2026

Immunity and Inflammation in Alzheimer's Disease: A Narrative Review on Mechanisms and Therapeutic Prospects.

This review systematically summarizes the core pathophysiological mechanisms by which inflammatory and immune dysfunctions contribute to AD pathogenesis and explores potential therapeutic interventions targeting these mechanisms, thereby providing theoretical insights for clinical translational research on AD treatment...

Lu-Ping Chi, Feng-Qing Xu, Xiao-Ying Dai et al. · 0 citations
Review Open access 2026

Microglia statuses in Alzheimer’s disease and lessons from anti-tumor microglia

Alzheimer’s disease (AD) and related dementias are closely associated with alterations in microglial states. These microglial changes occur in response to amyloid-β (Aβ) accumulation and aberrant tau phosphorylation and can either protect against or exacerbate AD progression, depending on factors such as disease stage,...

Julia Cai, Yellamandayya Vadlamudi, Praveen Agrawal · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.